Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
Research suggests that a small shift in how you move through a plate may matter more than you’d expect, and experts say it’s ...
Shared decision-making—balancing clinical data with the patient's personal, logistical, and risk-tolerance factors—is ...
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.
Genetic variants that cause rare disorders may remain elusive even after expansive testing, such as exome sequencing. The diagnostic yield of genome sequencing, particularly after a negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback